Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 111

1.

NEAT1-TFE3 and KAT6A-TFE3 renal cell carcinomas, new members of MiT family translocation renal cell carcinoma.

Pei J, Cooper H, Flieder DB, Talarchek JN, Al-Saleem T, Uzzo RG, Dulaimi E, Patchefsky AS, Testa JR, Wei S.

Mod Pathol. 2019 May;32(5):710-716. doi: 10.1038/s41379-018-0191-7. Epub 2019 Jan 8.

2.

Application of Chromosome Microarray Analysis for the Differential Diagnosis of Low-grade Renal Cell Carcinoma With Clear Cell and Papillary Features.

Pei J, Al-Saleem T, Uzzo RG, Dulaimi E, Testa JR, Wei S.

Appl Immunohistochem Mol Morphol. 2018 Nov 28. doi: 10.1097/PAI.0000000000000704. [Epub ahead of print]

PMID:
30499818
3.

The correlation between gain of chromosome 8q and survival in patients with clear and papillary renal cell carcinoma.

Mehrazin R, Dulaimi E, Uzzo RG, Devarjan K, Pei J, Smaldone MC, Kutikov A, Testa JR, Al-Saleem T.

Ther Adv Urol. 2017 Oct 31;10(1):3-10. doi: 10.1177/1756287217732660. eCollection 2018 Jan.

4.

Prostate Cancer Patients' Understanding of the Gleason Scoring System: Implications for Shared Decision-Making.

Tagai EK, Miller SM, Kutikov A, Diefenbach MA, Gor RA, Al-Saleem T, Chen DYT, Fleszar S, Roy G.

J Cancer Educ. 2019 Jun;34(3):441-445. doi: 10.1007/s13187-018-1320-1.

5.

NK cell dysfunction in chronic lymphocytic leukemia is associated with loss of the mature cells expressing inhibitory killer cell Ig-like receptors.

MacFarlane AW 4th, Jillab M, Smith MR, Alpaugh RK, Cole ME, Litwin S, Millenson MM, Al-Saleem T, Cohen AD, Campbell KS.

Oncoimmunology. 2017 May 19;6(7):e1330235. doi: 10.1080/2162402X.2017.1330235. eCollection 2017.

6.

The Pathology and Molecular Genetics of Sarcomatoid Renal Cell Carcinoma: A Mini-Review.

Wei S, Al-Saleem T.

J Kidney Cancer VHL. 2017 May 22;4(2):19-23. doi: 10.15586/jkcvhl.2017.70. eCollection 2017. Review.

7.

Low Level of Blood CD4+ T Cells Is an Independent Predictor of Inferior Progression-free Survival in Diffuse Large B-cell Lymphoma.

Judd J, Dulaimi E, Li T, Millenson MM, Borghaei H, Smith MR, Al-Saleem T.

Clin Lymphoma Myeloma Leuk. 2017 Feb;17(2):83-88. doi: 10.1016/j.clml.2016.11.005. Epub 2016 Nov 30.

PMID:
28027895
8.

Post-radiotherapy prostate biopsies reveal heightened apex positivity relative to other prostate regions sampled.

Huang KT, Stoyanova R, Walker G, Sandler K, Studenski MT, Dogan N, Al-Saleem T, Buyyounouski MK, Horwitz EM, Pollack A.

Radiother Oncol. 2015 Apr;115(1):101-6. doi: 10.1016/j.radonc.2015.03.006. Epub 2015 May 8.

9.

Lymphopenia is an independent predictor of inferior outcome in papillary renal cell carcinoma.

Mehrazin R, Uzzo RG, Kutikov A, Ruth K, Tomaszewski JJ, Dulaimi E, Ginzburg S, Abbosh PH, Ito T, Corcoran AT, Chen DY, Smaldone MC, Al-Saleem T.

Urol Oncol. 2015 Sep;33(9):388.e19-25. doi: 10.1016/j.urolonc.2014.06.004. Epub 2014 Jul 11.

10.

PD-1 expression on peripheral blood cells increases with stage in renal cell carcinoma patients and is rapidly reduced after surgical tumor resection.

MacFarlane AW 4th, Jillab M, Plimack ER, Hudes GR, Uzzo RG, Litwin S, Dulaimi E, Al-Saleem T, Campbell KS.

Cancer Immunol Res. 2014 Apr;2(4):320-31. doi: 10.1158/2326-6066.CIR-13-0133. Epub 2013 Nov 25.

11.

MicroRNA expression signatures of stage, grade, and progression in clear cell RCC.

Gowrishankar B, Ibragimova I, Zhou Y, Slifker MJ, Devarajan K, Al-Saleem T, Uzzo RG, Cairns P.

Cancer Biol Ther. 2014 Mar 1;15(3):329-41. doi: 10.4161/cbt.27314. Epub 2013 Dec 18.

12.

Renal cell carcinoma metastasis to a contralateral oncocytoma in a patient presenting with bilateral synchronous renal tumors.

Mehrazin R, Wong YN, Wu H, Al-Saleem T, Smaldone M.

Clin Genitourin Cancer. 2013 Dec;11(4):e27-9. doi: 10.1016/j.clgc.2013.06.001. Epub 2013 Sep 12. No abstract available.

PMID:
24035154
13.

Low NK cell counts in peripheral blood are associated with inferior overall survival in patients with follicular lymphoma.

Shafer D, Smith MR, Borghaei H, Millenson MM, Li T, Litwin S, Anad R, Al-Saleem T.

Leuk Res. 2013 Oct;37(10):1213-5. doi: 10.1016/j.leukres.2013.07.038. Epub 2013 Aug 7.

14.

Coexisting hybrid malignancy in a solitary sporadic solid benign renal mass: implications for treating patients following renal biopsy.

Ginzburg S, Uzzo R, Al-Saleem T, Dulaimi E, Walton J, Corcoran A, Plimack E, Mehrazin R, Tomaszewski J, Viterbo R, Chen DY, Greenberg R, Smaldone M, Kutikov A.

J Urol. 2014 Feb;191(2):296-300. doi: 10.1016/j.juro.2013.07.059. Epub 2013 Jul 27.

15.

Gleason scoring at a comprehensive cancer center: what's the difference?

Townsend NC, Ruth K, Al-Saleem T, Horwitz EM, Sobczak M, Uzzo RG, Viterbo R, Buyyounouski MK.

J Natl Compr Canc Netw. 2013 Jul;11(7):812-9.

16.

Germline Mutations in Mtap Cooperate with Myc to Accelerate Tumorigenesis in Mice.

Kadariya Y, Tang B, Wang L, Al-Saleem T, Hayakawa K, Slifker MJ, Kruger WD.

PLoS One. 2013 Jun 26;8(6):e67635. doi: 10.1371/journal.pone.0067635. Print 2013.

17.

Is there a benefit to frozen section analysis at the time of partial nephrectomy?

Sterious SN, Simhan J, Smaldone MC, Tsai KJ, Canter D, Wameedh E, Li T, Helstrom J, Viterbo R, Chen DY, Greenberg RE, Kutikov A, Al-Saleem T, Uzzo RG.

Can J Urol. 2013 Jun;20(3):6778-84.

PMID:
23783047
18.

Murine mantle cell lymphoma model cell line.

Smith MR, Joshi I, Pei J, Slifker M, Jin F, Testa JR, Al-Saleem T.

Leukemia. 2013 Jul;27(7):1592-4. doi: 10.1038/leu.2012.370. Epub 2012 Dec 28. No abstract available.

PMID:
23271511
19.

Lymphopenia is an independent predictor of inferior outcome in clear cell renal carcinoma.

Saroha S, Uzzo RG, Plimack ER, Ruth K, Al-Saleem T.

J Urol. 2013 Feb;189(2):454-61. doi: 10.1016/j.juro.2012.09.166. Epub 2012 Oct 4.

20.

Tetanus toxoid reactive lymphadenopathy masquerading as T-cell lymphoma.

White CK, Al-Saleem T, Skarbnik AP, Smith MR.

Future Oncol. 2012 May;8(5):631-4. doi: 10.2217/fon.12.37.

PMID:
22646776
21.

Elevated expression of stromal palladin predicts poor clinical outcome in renal cell carcinoma.

Gupta V, Bassi DE, Simons JD, Devarajan K, Al-Saleem T, Uzzo RG, Cukierman E.

PLoS One. 2011;6(6):e21494. doi: 10.1371/journal.pone.0021494. Epub 2011 Jun 28.

22.

Metanephric adenofibroma: robotic partial nephrectomy of a large Wilms' tumor variant.

Piotrowski Z, Canter DJ, Kutikov A, Al-Saleem T, Pei J, Testa JR, Uzzo RG.

Can J Urol. 2010 Aug;17(4):5309-12.

PMID:
20735912
23.

Global reactivation of epigenetically silenced genes in prostate cancer.

Ibragimova I, Ibáñez de Cáceres I, Hoffman AM, Potapova A, Dulaimi E, Al-Saleem T, Hudes GR, Ochs MF, Cairns P.

Cancer Prev Res (Phila). 2010 Sep;3(9):1084-92. doi: 10.1158/1940-6207.CAPR-10-0039. Epub 2010 Aug 10.

24.

Combined classical cytogenetics and microarray-based genomic copy number analysis reveal frequent 3;5 rearrangements in clear cell renal cell carcinoma.

Pei J, Feder MM, Al-Saleem T, Liu Z, Liu A, Hudes GR, Uzzo RG, Testa JR.

Genes Chromosomes Cancer. 2010 Jul;49(7):610-9. doi: 10.1002/gcc.20771.

25.

Pediatric nodal marginal zone lymphoma may develop in the adult population.

Gitelson E, Al-Saleem T, Robu V, Millenson MM, Smith MR.

Leuk Lymphoma. 2010 Jan;51(1):89-94. doi: 10.3109/10428190903349670.

26.

Extranodal NK/T-cell lymphoma nasal type: efficacy of pegaspargase. Report of two patients from the United Sates and review of literature.

Reyes VE Jr, Al-Saleem T, Robu VG, Smith MR.

Leuk Res. 2010 Jan;34(1):e50-4. doi: 10.1016/j.leukres.2009.09.002. Epub 2009 Sep 27. Review. No abstract available.

27.

The importance of protein kinase A in prostate cancer: relationship to patient outcome in Radiation Therapy Oncology Group trial 92-02.

Pollack A, Bae K, Khor LY, Al-Saleem T, Hammond ME, Venkatesan V, Byhardt RW, Asbell SO, Shipley WU, Sandler HM.

Clin Cancer Res. 2009 Sep 1;15(17):5478-84. doi: 10.1158/1078-0432.CCR-08-2704. Epub 2009 Aug 25.

28.

Mice heterozygous for germ-line mutations in methylthioadenosine phosphorylase (MTAP) die prematurely of T-cell lymphoma.

Kadariya Y, Yin B, Tang B, Shinton SA, Quinlivan EP, Hua X, Klein-Szanto A, Al-Saleem TI, Bassing CH, Hardy RR, Kruger WD.

Cancer Res. 2009 Jul 15;69(14):5961-9. doi: 10.1158/0008-5472.CAN-09-0145. Epub 2009 Jun 30.

29.

MDM2 and Ki-67 predict for distant metastasis and mortality in men treated with radiotherapy and androgen deprivation for prostate cancer: RTOG 92-02.

Khor LY, Bae K, Paulus R, Al-Saleem T, Hammond ME, Grignon DJ, Che M, Venkatesan V, Byhardt RW, Rotman M, Hanks GE, Sandler HM, Pollack A.

J Clin Oncol. 2009 Jul 1;27(19):3177-84. doi: 10.1200/JCO.2008.19.8267. Epub 2009 May 26.

30.

Review: lymphomatoid granulomatosis: challenges in diagnosis and treatment.

Gitelson E, Al-Saleem T, Smith MR.

Clin Adv Hematol Oncol. 2009 Jan;7(1):68-70. Review. No abstract available.

PMID:
19274044
31.

The role of the Birt-Hogg-Dubé protein in mTOR activation and renal tumorigenesis.

Hartman TR, Nicolas E, Klein-Szanto A, Al-Saleem T, Cash TP, Simon MC, Henske EP.

Oncogene. 2009 Apr 2;28(13):1594-604. doi: 10.1038/onc.2009.14. Epub 2009 Feb 23.

32.

Cutaneous precursor B-cell lymphoblastic lymphoma in 2 adult patients: clinicopathologic and molecular cytogenetic studies with a review of the literature.

Shafer D, Wu H, Al-Saleem T, Reddy K, Borghaei H, Lessin S, Smith M.

Arch Dermatol. 2008 Sep;144(9):1155-62. doi: 10.1001/archderm.144.9.1155. Review.

PMID:
18794461
33.

Protein kinase A RI-alpha predicts for prostate cancer outcome: analysis of radiation therapy oncology group trial 86-10.

Khor LY, Bae K, Al-Saleem T, Hammond EH, Grignon DJ, Sause WT, Pilepich MV, Okunieff PP, Sandler HM, Pollack A.

Int J Radiat Oncol Biol Phys. 2008 Aug 1;71(5):1309-15. doi: 10.1016/j.ijrobp.2007.12.010. Epub 2008 May 1.

34.

Cutaneous plasmablastic lymphoma.

Jambusaria A, Shafer D, Wu H, Al-Saleem T, Perlis C.

J Am Acad Dermatol. 2008 Apr;58(4):676-8. doi: 10.1016/j.jaad.2007.08.009.

PMID:
18342714
35.

Pathologic concordance of sporadic synchronous bilateral renal masses.

Rothman J, Crispen PL, Wong YN, Al-Saleem T, Fox E, Uzzo RG.

Urology. 2008 Jul;72(1):138-42. doi: 10.1016/j.urology.2008.01.043. Epub 2008 Mar 12.

36.

Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer.

Potapova A, Hoffman AM, Godwin AK, Al-Saleem T, Cairns P.

Cancer Res. 2008 Feb 15;68(4):998-1002. doi: 10.1158/0008-5472.CAN-07-2418.

37.

Bcl-2 and Bax expression predict prostate cancer outcome in men treated with androgen deprivation and radiotherapy on radiation therapy oncology group protocol 92-02.

Khor LY, Moughan J, Al-Saleem T, Hammond EH, Venkatesan V, Rosenthal SA, Ritter MA, Sandler HM, Hanks GE, Shipley WU, Pollack A.

Clin Cancer Res. 2007 Jun 15;13(12):3585-90.

38.

Role of radiotherapy in ductal (endometrioid) carcinoma of the prostate.

Eade TN, Al-Saleem T, Horwitz EM, Buyyounouski MK, Chen DY, Pollack A.

Cancer. 2007 May 15;109(10):2011-5.

39.

The proportion of prostate biopsy tissue with Gleason pattern 4 or 5 predicts for biochemical and clinical outcome after radiotherapy for prostate cancer.

D'Ambrosio DJ, Hanlon AL, Al-Saleem T, Feigenberg SJ, Horwitz EM, Uzzo RG, Pollack A, Buyyounouski MK.

Int J Radiat Oncol Biol Phys. 2007 Mar 15;67(4):1082-7. Epub 2007 Jan 22.

PMID:
17241749
40.

Cutaneous B-cell lymphoma responds to rituximab: a report of five cases and a review of the literature.

Gitelson E, Al-Saleem T, Millenson M, Lessin S, Smith MR.

Leuk Lymphoma. 2006 Sep;47(9):1902-7.

PMID:
17065004
41.

Identification of novel target genes by an epigenetic reactivation screen of renal cancer.

Ibanez de Caceres I, Dulaimi E, Hoffman AM, Al-Saleem T, Uzzo RG, Cairns P.

Cancer Res. 2006 May 15;66(10):5021-8.

42.

Murine model for mantle cell lymphoma.

Smith MR, Joshi I, Jin F, Al-Saleem T.

Leukemia. 2006 May;20(5):891-3. No abstract available.

PMID:
16525491
43.

Renal oncocytoma with loss of chromosomes Y and 1 evolving to papillary carcinoma in connection with gain of chromosome 7. Coincidence or progression?

Al-Saleem T, Balsara BR, Liu Z, Feder M, Testa JR, Wu H, Greenberg RE.

Cancer Genet Cytogenet. 2005 Nov;163(1):81-5.

PMID:
16271962
44.

Pure red cell aplasia in B-cell lymphoproliferative disorder treated with rituximab: report of two cases and review of the literature.

Narra K, Borghaei H, Al-Saleem T, Höglund M, Smith MR.

Leuk Res. 2006 Jan;30(1):109-14. Epub 2005 Jul 25.

PMID:
16043218
45.

MDM2 as a predictor of prostate carcinoma outcome: an analysis of Radiation Therapy Oncology Group Protocol 8610.

Khor LY, Desilvio M, Al-Saleem T, Hammond ME, Grignon DJ, Sause W, Pilepich M, Okunieff P, Sandler H, Pollack A; Radiation Therapy Oncology Group.

Cancer. 2005 Sep 1;104(5):962-7.

46.

Prior abdominal surgery and radiation do not complicate the retroperitoneoscopic approach to the kidney or adrenal gland.

Viterbo R, Greenberg RE, Al-Saleem T, Uzzo RG.

J Urol. 2005 Aug;174(2):446-50.

PMID:
16006862
47.

Immunoproliferative small intestinal disease (IPSID): a model for mature B-cell neoplasms.

Al-Saleem T, Al-Mondhiry H.

Blood. 2005 Mar 15;105(6):2274-80. Epub 2004 Nov 12. Review.

48.

Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.

Dulaimi E, Hillinck J, Ibanez de Caceres I, Al-Saleem T, Cairns P.

Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6189-93.

49.

Promoter hypermethylation profile of kidney cancer.

Dulaimi E, Ibanez de Caceres I, Uzzo RG, Al-Saleem T, Greenberg RE, Polascik TJ, Babb JS, Grizzle WE, Cairns P.

Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):3972-9.

50.

The genetics of renal oncocytosis: a possible model for neoplastic progression.

Al-Saleem T, Cairns P, Dulaimi EA, Feder M, Testa JR, Uzzo RG.

Cancer Genet Cytogenet. 2004 Jul 1;152(1):23-8.

PMID:
15193438

Supplemental Content

Loading ...
Support Center